Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial

CONCLUSION: Topical diclofenac prevented HFS in patients receiving capecitabine. This trial supports the use of topical diclofenac to prevent capecitabine-associated HFS.PMID:38412399 | DOI:10.1200/JCO.23.01730

Source: Clinical Genitourinary Cancer - February 27, 2024 Category: Cancer & Oncology Authors: Akhil Santhosh Atul Sharma Sameer Bakhshi Akash Kumar Vinod Sharma Prabhat Singh Malik Raja Pramanik Ajay Gogia Chandra Prakash Prasad Tushar Sehgal Sneha Gund Arundhathi Dev Winson Y Cheung R M Pandey Saran Kumar Ishaan Gupta Atul Batra D-TORCH Trial Inv Source Type: research